CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
REVENUES:
License fees	$ 300,079	$ 362,249	$ 594,582	$ 712,078
Royalties from product sales	76,109	103,315	173,996	210,914
Grant income	640,034	693,480	1,215,614	777,293
Sale of research products	90,478	57,281	189,068	124,005
Total revenues	1,106,700	1,216,325	2,173,260	1,824,290
Cost of sales	(251,265)	(180,811)	(383,179)	(363,560)
Gross Profit	855,435	1,035,514	1,790,081	1,460,730
EXPENSES:
Research and development	(9,081,137)	(5,530,395)	(17,469,570)	(10,975,825)
General and administrative	(4,835,972)	(3,621,570)	(8,503,259)	(7,005,091)
Total operating expenses	(13,917,109)	(9,151,965)	(25,972,829)	(17,980,916)
Loss from operations	(13,061,674)	(8,116,451)	(24,182,748)	(16,520,186)
OTHER INCOME/(EXPENSES):
Interest (expense)/income, net	(10,024)	579	(18,398)	1,522
Gain/(loss) on sale or write off of fixed assets	0	800	(8,576)	(710)
Other income/(expense), net	164,732	(80,541)	242,868	(109,520)
Total other expenses, net	154,708	(79,162)	215,894	(108,708)
LOSS BEFORE INCOME TAX BENEFIT	(12,906,966)	(8,195,613)	(23,966,854)	(16,628,894)
Deferred income tax benefit	1,513,258	0	2,862,284	0
NET LOSS	(11,393,708)	(8,195,613)	(21,104,570)	(16,628,894)
Net loss attributable to noncontrolling interest	1,873,518	645,848	3,495,735	1,346,503
NET LOSS ATTRIBUTABLE TO BIOTIME, INC.	(9,520,190)	(7,549,765)	(17,608,835)	(15,282,391)
Dividends on preferred shares	(34,038)	0	(34,038)	0
Net loss attributable to common shareholders	(9,554,228)	(7,549,765)	(17,642,873)	(15,282,391)
Unrealized gain/(loss) on available-for-sale assets	1,120	0	(1,530)	0
Foreign currency translation (loss)/gain	(74,831)	28,857	(182,071)	177,294
TOTAL COMPREHENSIVE NET LOSS	$ (9,593,901)	$ (7,520,908)	$ (17,792,436)	$ (15,105,097)
BASIC AND DILUTED NET LOSS PER COMMON SHARE	$ (0.16)	$ (0.14)	$ (0.29)	$ (0.29)
WEIGHTED AVERAGE NUMBER OF COMMON STOCK OUTSTANDING: BASIC AND DILUTED	61,498,164	53,791,434	61,498,164	52,490,767